PRIMARY BREAST LYMPHOMA – A RARE DISEASE
Keywords:
primary breast lymphoma, surgical therapy, chemotherapy, radiotherapy
Abstract
Primary breast lymphoma (PBL) is breast lymphoma that develops only in the breast without lymphoma disease in any other area of the body. PML constitutes less than 0.5% of all breast cancers. Treatment options are not clear because primary breast lymphomas are rare. The aim of this review is to raise awareness about PBL disease, to give information about its symptoms, choice of diagnosis and treatment methods.
References
[1] Moura C, Leite MI, Parreira R, Medeiros A. Primary breast lymphoma. J Surg Case Rep. 2020;2020(1):rjz405.
[2] Zhou C, Lv K, Lin D, Yu Y, Xu M, Bu Y. Radiological analysis of breast lymphoma: Experiences from cases series studies. Medicine (Baltimore). 2019;98(48):e18101.
[3] Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin's lymphomas of the female breast. Cancer. 1992;69:725–35.
[4] Al Battah AH, Al Kuwari EA, Hascsi Z, Nashwan AJ, Elomari H, Elsabah H, et al. Diffuse large b-cell breast lymphoma: a case series. Clin Med Insights Blood Disord. 2017;10:1179545X17725034.
[5] Radkani P, Joshi D, Paramo JC, Mesko TW. Primary breast lymphoma: 30 years of experience with diagnosis and treatment at a single medical center. JAMA Surg. 2014;149:91‐93.
[6] DobrotinaAF,ZlotnikovaZB.Generalized sarcomatosis (lymphosarcomatosis) in pregnancy with unusual with unusual bilateral involvement of the breasts [in Russian]. Vopr Onkol. 1959;5(5):613-616.
[7] Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
[8] Joks M, Mys ́liwiec K, Lewandowski K. Primary breast lymphoma – a review of the literature and report of three cases. Arch Med Sci. 2011;7:27–33
[9] Picasso R, Tagliafico A, Calabrese M, Martinoli C, Pistoia F, Rossi A, et al. Primary and secondary breast lymphoma: focus on epidemiology and imaging features. Pathol Oncol Res. 2020;26(3):1483-1488
[10] Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF et al. Primary breast lymphoma. The role of mastectomy and the importance of lymph node status. Ann Surg. 2007;245:784–9.
[11] Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014;40(8):900–908
[12] Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014;165:358–363
[13] Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary Breast Lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017;109:djw294. doi:10.1093/jnci/djw294
[14] Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the international extranodal lymphoma study group. Ann Oncol. 2008;19: 233–241.
[15] Lyou CY, Yang SK, Choe DH, Lee BH, Kim KH. Mammographic and sonographic findings of primary breast lymphoma. Clin Imaging 2007;31:234–8.
[16] Surov A, Holzhausen HJ, Wienke A, Schmidt J, Thomssen C, Arnold D, et al. Primary and secondary breast lymphoma: Prevalence, clinical signs and radiological features. Br J Radiol. 2012;85:e195–205.
[17] Maurya V, Singh G, Ram B, Ganguli P. Multimodality imaging features of primary breast lymphoma - A rare entity. Indian J Radiol Imaging. 2019;29:85–88.
[18] Avilés A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology 2005;69(3):256-60.
[19] Luo H, Yi P, Wang W, Li K, Meng L, Li J, et al. Clinicopathological features, treatment, and prognosis in primary diffuse large b cell lymphoma of the breast: a retrospective study of 46 patients. Med Sci Monit. 2019;25:8671–82.
[20] Uesato M, Miyazawa Y, Gunji Y, Ochiai T. Primary non-Hodgkin's lymphoma of the breast: report of a case with special reference to 380 cases in the Japanese literature. Breast Cancer. 2005;12(2):154‐158.
[21] Mambo NC, Burke JS, Butler JJ: Primary malignant lymphoma of the breast. Cancer 1977;39:2033-40.
[22] DeCosse JJ, Berg JW, Fracchia AA, Farrow JH: Primary Lymphosarcoma of the Breast. Cancer 1961;15:1264-8.
[23] Hu S, Song Y, Sun X et al: Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure. Cancer Sci. 2018;109: 3943–52.
[2] Zhou C, Lv K, Lin D, Yu Y, Xu M, Bu Y. Radiological analysis of breast lymphoma: Experiences from cases series studies. Medicine (Baltimore). 2019;98(48):e18101.
[3] Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin's lymphomas of the female breast. Cancer. 1992;69:725–35.
[4] Al Battah AH, Al Kuwari EA, Hascsi Z, Nashwan AJ, Elomari H, Elsabah H, et al. Diffuse large b-cell breast lymphoma: a case series. Clin Med Insights Blood Disord. 2017;10:1179545X17725034.
[5] Radkani P, Joshi D, Paramo JC, Mesko TW. Primary breast lymphoma: 30 years of experience with diagnosis and treatment at a single medical center. JAMA Surg. 2014;149:91‐93.
[6] DobrotinaAF,ZlotnikovaZB.Generalized sarcomatosis (lymphosarcomatosis) in pregnancy with unusual with unusual bilateral involvement of the breasts [in Russian]. Vopr Onkol. 1959;5(5):613-616.
[7] Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
[8] Joks M, Mys ́liwiec K, Lewandowski K. Primary breast lymphoma – a review of the literature and report of three cases. Arch Med Sci. 2011;7:27–33
[9] Picasso R, Tagliafico A, Calabrese M, Martinoli C, Pistoia F, Rossi A, et al. Primary and secondary breast lymphoma: focus on epidemiology and imaging features. Pathol Oncol Res. 2020;26(3):1483-1488
[10] Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF et al. Primary breast lymphoma. The role of mastectomy and the importance of lymph node status. Ann Surg. 2007;245:784–9.
[11] Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014;40(8):900–908
[12] Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014;165:358–363
[13] Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary Breast Lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017;109:djw294. doi:10.1093/jnci/djw294
[14] Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the international extranodal lymphoma study group. Ann Oncol. 2008;19: 233–241.
[15] Lyou CY, Yang SK, Choe DH, Lee BH, Kim KH. Mammographic and sonographic findings of primary breast lymphoma. Clin Imaging 2007;31:234–8.
[16] Surov A, Holzhausen HJ, Wienke A, Schmidt J, Thomssen C, Arnold D, et al. Primary and secondary breast lymphoma: Prevalence, clinical signs and radiological features. Br J Radiol. 2012;85:e195–205.
[17] Maurya V, Singh G, Ram B, Ganguli P. Multimodality imaging features of primary breast lymphoma - A rare entity. Indian J Radiol Imaging. 2019;29:85–88.
[18] Avilés A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology 2005;69(3):256-60.
[19] Luo H, Yi P, Wang W, Li K, Meng L, Li J, et al. Clinicopathological features, treatment, and prognosis in primary diffuse large b cell lymphoma of the breast: a retrospective study of 46 patients. Med Sci Monit. 2019;25:8671–82.
[20] Uesato M, Miyazawa Y, Gunji Y, Ochiai T. Primary non-Hodgkin's lymphoma of the breast: report of a case with special reference to 380 cases in the Japanese literature. Breast Cancer. 2005;12(2):154‐158.
[21] Mambo NC, Burke JS, Butler JJ: Primary malignant lymphoma of the breast. Cancer 1977;39:2033-40.
[22] DeCosse JJ, Berg JW, Fracchia AA, Farrow JH: Primary Lymphosarcoma of the Breast. Cancer 1961;15:1264-8.
[23] Hu S, Song Y, Sun X et al: Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure. Cancer Sci. 2018;109: 3943–52.
Published
2020-09-21
How to Cite
Ekci, B., Agturk, G., & Cinar, E. (2020). PRIMARY BREAST LYMPHOMA – A RARE DISEASE. Romanian Journal of Clinical Research, 3(2), 62-64. https://doi.org/10.33695/rjcr.v3i2.59
Section
Articles
